{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:24:34Z","timestamp":1794864274803,"version":"4.9.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["No. CSTB2024NSCQ-MSX0706"],"award-info":[{"award-number":["No. CSTB2024NSCQ-MSX0706"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["No. CSTB2024NSCQ-MSX0706"],"award-info":[{"award-number":["No. CSTB2024NSCQ-MSX0706"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Globally, common gynecological disorders such as Polycystic Ovary Syndrome (PCOS), endometriosis, uterine fibroids (non-malignant gynecological diseases), as well as cervical cancer, uterine cancer, and ovarian cancer (gynecological cancers), profoundly impact women\u2019s physical and mental health. The burden of these diseases exhibits significant geographical disparities across different countries and regions, making a comprehensive and precise assessment of the global burden of gynecological diseases particularly crucial. Such an assessment will facilitate the development of region-specific prevention and treatment strategies, contributing to a more effective response to these health challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Incidence, prevalence, mortality rates, and Disability-Adjusted Life Years (DALYs) data for the aforementioned gynecological conditions were obtained from the 2021 Global Burden of Disease (GBD) study and analyzed by age, location, and year. The burden associated with gynecological diseases was analyzed based on the Socio-demographic Index (SDI) and attributable risk factors. The Estimated Annual Percentage Change (EAPC) and its 95% Confidence Interval (CI) were used to assess temporal trends in burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, uterine fibroids were the leading non-malignant gynecological condition contributing to the highest Age-Standardized Incidence Rate (ASIR) and Age-Standardized Prevalence Rate (ASPR), with rates of 250.93 and 2841.07 per 100,000, respectively. Cervical cancer was the main contributor to the Age-Standardized Mortality Rate (ASMR) and Age-Standardized Disability Rate (ASDR) among the eight selected gynecological diseases, with rates of 6.62 and 226.28 per 100,000, respectively. From 1990 to 2021, the ASIR and ASPR for non-malignant gynecological conditions, such as PCOS and uterine fibroids, increased, while the ASDR for PCOS also rose. Among gynecological cancers, the ASIR for uterine cancer increased, while the ASPR for cervical cancer rose. However, the ASIR for cervical and ovarian cancers decreased, along with reductions in the ASMR and ASDR for these cancers and uterine cancer. There were notable regional disparities based on the SDI. In 2021, lower SDI regions had higher incidence, prevalence, mortality rates, and DALYs for endometriosis and cervical cancer, whereas higher SDI regions saw higher rates for PCOS, uterine fibroids, ovarian cancer, and uterine cancer, with more significant mortality and DALYs for ovarian and uterine cancers. The age distribution of these conditions varied. Non-malignant gynecological conditions, such as PCOS and uterine fibroids, primarily affect women aged 30\u201334 and 40\u201369. Endometriosis is most common in women aged 20\u201334, particularly between 25 and 29. Gynecological cancers, including cervical, uterine, and ovarian cancers, predominantly affect women over 35, especially between 40 and 69, with cervical cancer peaking at ages 50\u201354. Regarding attributable risk factors globally, 1% of cervical cancer deaths were linked to unsafe sexual behaviors, while a high Body Mass Index(BMI) contributed to 0.09% of ovarian cancer deaths and 0.34% of uterine cancer deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global burden of these six gynecological conditions poses a significant public health challenge. There is an urgent need for international collaboration to advance the development of age and regionally differentiated management strategies for gynecological diseases, including the development of effective diagnostic screening tools and the implementation of high-quality, targeted prevention and treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-22881-3","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:32:27Z","timestamp":1747182747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8130-7516","authenticated-orcid":false,"given":"Wei-Zhen","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Yu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ren","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-He","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-8281","authenticated-orcid":false,"given":"Tai-Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"22881_CR1","doi-asserted-by":"publisher","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","volume":"74","author":"P Sun","year":"2024","unstructured":"Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T, et al. Global, regional, and National burden of female cancers in women of child-bearing age, 1990\u20132021: analysis of data from the global burden of disease study 2021. EClinicalMedicine. 2024;74:102713.","journal-title":"EClinicalMedicine"},{"key":"22881_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.amepre.2024.06.022","volume":"67","author":"Y Cao","year":"2024","unstructured":"Cao Y, Guo Y, Long Z, Wu Y, Pei B, Ye J, et al. The global burden of gynecological diseases from 1990 to 2019. Am J Prev Med. 2024;67:698\u2013704.","journal-title":"Am J Prev Med"},{"key":"22881_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12885-025-13741-9","volume":"25","author":"Y Li","year":"2025","unstructured":"Li Y, Song W, Gao P, Guan X, Wang B, Zhang L, et al. Global, regional, and National burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021. BMC Cancer. 2025;25:330.","journal-title":"BMC Cancer"},{"key":"22881_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","volume":"18","author":"T Li","year":"2025","unstructured":"Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, et al. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. J Hematol Oncol. 2025;18:5.","journal-title":"J Hematol Oncol"},{"key":"22881_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-021-00310-y","volume":"9","author":"M Yi","year":"2021","unstructured":"Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women\u2019s cancers from 1990 to 2019 at the global, regional, and National levels: a population-based study. Biomark Res. 2021;9:55.","journal-title":"Biomark Res"},{"key":"22881_CR6","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.5114\/aoms\/171786","volume":"19","author":"B Li","year":"2023","unstructured":"Li B, Wang F, Chen L, Tong H. Global epidemiological characteristics of uterine fibroids. Arch Med Sci. 2023;19:1802\u201310.","journal-title":"Arch Med Sci"},{"key":"22881_CR7","doi-asserted-by":"publisher","first-page":"e0306991","DOI":"10.1371\/journal.pone.0306991","volume":"19","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhu Y, Wang J, Hu H, Jin Y, Mao X, et al. Global burden and epidemiological prediction of polycystic ovary syndrome from 1990 to 2019: A systematic analysis from the global burden of disease study 2019. PLoS ONE. 2024;19:e0306991.","journal-title":"PLoS ONE"},{"key":"22881_CR8","first-page":"1347","volume":"4","author":"S Izetbegovic","year":"2013","unstructured":"Izetbegovic S, Alajbegovic J, Mutevelic A, Pasagic A, Masic I. Prevention of diseases in gynecology. Int J Prev Med. 2013;4:1347\u201358.","journal-title":"Int J Prev Med"},{"key":"22881_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/jpm13091284","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Han W, Wang H, Wang Z, Li B, Hong L. Spatiotemporal trends and Age-Period-Cohort analysis for the burden of Endometriosis-Related infertility: an analysis of the global burden of disease study 2019. J Pers Med. 2023;13:1284.","journal-title":"J Pers Med"},{"key":"22881_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","volume":"371","author":"KA Yonkers","year":"2008","unstructured":"Yonkers KA, O\u2019Brien PMS, Eriksson E. Premenstrual syndrome. Lancet. 2008;371:1200\u201310.","journal-title":"Lancet"},{"key":"22881_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331.","journal-title":"Nat Rev Endocrinol"},{"key":"22881_CR12","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.","journal-title":"Nat Rev Dis Primers"},{"key":"22881_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389:847\u201360.","journal-title":"Lancet"},{"key":"22881_CR14","unstructured":"Cervical cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 9 Nov 2024."},{"key":"22881_CR15","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical Cancer elimination initiative. Lancet Glob Health. 2023;11:e197\u2013206.","journal-title":"Lancet Glob Health"},{"key":"22881_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"22881_CR17","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376\u201388.","journal-title":"Lancet"},{"key":"22881_CR18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/jcm12051874","volume":"12","author":"J Liu","year":"2023","unstructured":"Liu J, Wang H, Wang Z, Han W, Hong L. The global, regional, and National uterine Cancer burden attributable to high BMI from 1990 to 2019: A systematic analysis of the global burden of disease study 2019. J Clin Med. 2023;12:1874.","journal-title":"J Clin Med"},{"key":"22881_CR19","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2100\u201332.","journal-title":"Lancet"},{"key":"22881_CR20","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"GBD 2021 Demographics Collaborators","year":"2024","unstructured":"GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet. 2024;403:1989\u20132056.","journal-title":"Lancet"},{"key":"22881_CR21","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"22881_CR22","first-page":"64","volume":"8","author":"C Zhu","year":"2021","unstructured":"Zhu C, Wang D-Q, Zi H, Huang Q, Gu J-M, Li L-Y, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8:64.","journal-title":"Mil Med Res"},{"key":"22881_CR23","first-page":"60","volume":"8","author":"H Zi","year":"2021","unstructured":"Zi H, He S-H, Leng X-Y, Xu X-F, Huang Q, Weng H, et al. Global, regional, and National burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990\u20132019. Mil Med Res. 2021;8:60.","journal-title":"Mil Med Res"},{"key":"22881_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3961\/jpmph.21.597","volume":"55","author":"Y-E Kim","year":"2022","unstructured":"Kim Y-E, Jung Y-S, Ock M, Yoon S-J. DALY Estimation approaches: Understanding and using the Incidence-based approach and the Prevalence-based approach. J Prev Med Public Health. 2022;55:10\u20138.","journal-title":"J Prev Med Public Health"},{"key":"22881_CR25","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","unstructured":"GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1223\u201349.","journal-title":"Lancet"},{"key":"22881_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"22881_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.chest.2023.09.028","volume":"165","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wen H, Bai J, Sun J, Chen J, Yu C. Disease burden and prediction analysis of tracheal, bronchus, and lung Cancer attributable to residential radon, solid fuels, and particulate matter pollution under different sociodemographic transitions from 1990 to 2030. Chest. 2024;165:446\u201360.","journal-title":"Chest"},{"key":"22881_CR28","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"22881_CR29","first-page":"64","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu M-Y, Luo L-S, Huang Q, Luo P-C, Luan H-H, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11:64.","journal-title":"Mil Med Res"},{"key":"22881_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1008953201688","volume":"11","author":"BF Hankey","year":"2000","unstructured":"Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 2000;11:31\u20135.","journal-title":"Cancer Causes Control"},{"key":"22881_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70:674\u201383.","journal-title":"J Hepatol"},{"key":"22881_CR32","doi-asserted-by":"publisher","first-page":"4528704","DOI":"10.1155\/2018\/4528704","volume":"2018","author":"C Chen","year":"2018","unstructured":"Chen C, Chen Y, Zhang Y, Sun W, Jiang Y, Song Y, et al. Association between dietary patterns and precocious puberty in children: A Population-Based study. Int J Endocrinol. 2018;2018:4528704.","journal-title":"Int J Endocrinol"},{"key":"22881_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2147\/DMSO.S216791","volume":"12","author":"W Kopp","year":"2019","unstructured":"Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes. 2019;12:2221\u201336.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"22881_CR34","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1530\/EC-18-0502","volume":"8","author":"RJ Rodgers","year":"2019","unstructured":"Rodgers RJ, Avery JC, Moore VM, Davies MJ, Azziz R, Stener-Victorin E, et al. Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus. Endocr Connect. 2019;8:R71\u20135.","journal-title":"Endocr Connect"},{"key":"22881_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2015.10.034","volume":"163","author":"SJ Han","year":"2015","unstructured":"Han SJ, Jung SY, Wu S-P, Hawkins SM, Park MJ, Kyo S, et al. Estrogen receptor \u0392 modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163:960\u201374.","journal-title":"Cell"},{"key":"22881_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.2756","volume":"222","author":"C Ng\u00f4","year":"2010","unstructured":"Ng\u00f4 C, Nicco C, Leconte M, Ch\u00e9reau C, Arkwright S, Vacher-Lavenu M-C, et al. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J Pathol. 2010;222:148\u201357.","journal-title":"J Pathol"},{"key":"22881_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.rbmo.2022.11.006","volume":"46","author":"R Qin","year":"2023","unstructured":"Qin R, Zheng F, Qin W, Wang J, Ma N, Tian W, et al. Progranulin promotes proliferation, migration and invasion via the PI3K\/Akt signalling pathway in a model of endometriosis. Reprod Biomed Online. 2023;46:425\u201335.","journal-title":"Reprod Biomed Online"},{"key":"22881_CR38","doi-asserted-by":"publisher","first-page":"e76808","DOI":"10.1371\/journal.pone.0076808","volume":"8","author":"S Matsuzaki","year":"2013","unstructured":"Matsuzaki S, Darcha C. Involvement of the Wnt\/\u03b2-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS ONE. 2013;8:e76808.","journal-title":"PLoS ONE"},{"key":"22881_CR39","doi-asserted-by":"publisher","first-page":"791860","DOI":"10.3389\/fendo.2022.791860","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Cai E, Cheng H, Ye X, Ma R, Zhu H, et al. FGA controls VEGFA secretion to promote angiogenesis by activating the VEGFR2-FAK signalling pathway. Front Endocrinol (Lausanne). 2022;13:791860.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"22881_CR40","doi-asserted-by":"publisher","first-page":"114909","DOI":"10.1016\/j.biopha.2023.114909","volume":"164","author":"M Zhang","year":"2023","unstructured":"Zhang M, Xu T, Tong D, Li S, Yu X, Liu B, et al. Research advances in endometriosis-related signaling pathways: A review. Biomed Pharmacother. 2023;164:114909.","journal-title":"Biomed Pharmacother"},{"key":"22881_CR41","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/s12889-023-15765-x","volume":"23","author":"Z Lou","year":"2023","unstructured":"Lou Z, Huang Y, Li S, Luo Z, Li C, Chu K, et al. Global, regional, and National time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990\u20132019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC Public Health. 2023;23:916.","journal-title":"BMC Public Health"},{"key":"22881_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N, Brisson M, HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394:497\u2013509.","journal-title":"Lancet"},{"key":"22881_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","volume":"127","author":"EEL Jansen","year":"2020","unstructured":"Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vok\u00f3 Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207\u201323.","journal-title":"Eur J Cancer"},{"key":"22881_CR44","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","volume":"49","author":"S Vaccarella","year":"2013","unstructured":"Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer. 2013;49:3262\u201373.","journal-title":"Eur J Cancer"},{"key":"22881_CR45","first-page":"954","volume":"79","author":"R Sankaranarayanan","year":"2001","unstructured":"Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79:954\u201362.","journal-title":"Bull World Health Organ"},{"key":"22881_CR46","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","volume":"4","author":"L Bruni","year":"2016","unstructured":"Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4:e453\u2013463.","journal-title":"Lancet Glob Health"},{"key":"22881_CR47","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","volume":"5","author":"E Gakidou","year":"2008","unstructured":"Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5:e132.","journal-title":"PLoS Med"},{"key":"22881_CR48","unstructured":"Cervical Cancer Elimination Initiative. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative. Accessed 9 Nov 2024."},{"key":"22881_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.3975633","volume":"228","author":"RC Grafstrom","year":"1985","unstructured":"Grafstrom RC, Curren RD, Yang LL, Harris CC. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. Science. 1985;228:89\u201391.","journal-title":"Science"},{"key":"22881_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40265-019-01249-z","volume":"80","author":"AC Cohen","year":"2020","unstructured":"Cohen AC, Roane BM, Leath CA. Novel therapeutics for recurrent cervical cancer: moving towards personalized therapy. Drugs. 2020;80:217\u201327.","journal-title":"Drugs"},{"key":"22881_CR51","doi-asserted-by":"publisher","first-page":"148265","DOI":"10.1016\/j.gene.2024.148265","volume":"909","author":"M Zhang","year":"2024","unstructured":"Zhang M, Xu T, Tong D, Yu X, Liu B, Jiang L, et al. MiR-136-5p in cancer: roles, mechanisms, and chemotherapy resistance. Gene. 2024;909:148265.","journal-title":"Gene"},{"key":"22881_CR52","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.2147\/OTT.S241818","volume":"13","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yang T, Li L. LncRNA FOXP4-AS1 is involved in cervical Cancer progression via regulating miR-136-5p\/CBX4 Axis. Onco Targets Ther. 2020;13:2347\u201355.","journal-title":"Onco Targets Ther"},{"key":"22881_CR53","doi-asserted-by":"publisher","first-page":"e20210405","DOI":"10.1590\/1678-4685-gmb-2021-0405","volume":"45","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang S. Systematic analyses of a novel circRNA-related MiRNAs prognostic signature for cervical Cancer. Genet Mol Biol. 2022;45:e20210405.","journal-title":"Genet Mol Biol"},{"key":"22881_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ygyno.2021.05.008","volume":"162","author":"CH Hemmingsen","year":"2021","unstructured":"Hemmingsen CH, Kjaer SK, Bennetsen AKK, Dehlendorff C, Baandrup L. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer. Gynecol Oncol. 2021;162:469\u201374.","journal-title":"Gynecol Oncol"},{"key":"22881_CR55","doi-asserted-by":"publisher","first-page":"103958","DOI":"10.1016\/j.esmoop.2024.103958","volume":"9","author":"Z Huang","year":"2024","unstructured":"Huang Z, Wang J, Liu H, Wang B, Qi M, Lyu Z, et al. Global trends in adolescent and young adult female cancer burden, 1990\u20132021: insights from the global burden of disease study. ESMO Open. 2024;9:103958.","journal-title":"ESMO Open"},{"key":"22881_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ygyno.2016.12.010","volume":"144","author":"AA Suarez","year":"2017","unstructured":"Suarez AA, Felix AS, Cohn DE. Bokhman redux: endometrial cancer types in the 21st century. Gynecol Oncol. 2017;144:243\u20139.","journal-title":"Gynecol Oncol"},{"key":"22881_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"22881_CR58","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","volume":"29","author":"L Ib\u00e1\u00f1ez","year":"2023","unstructured":"Ib\u00e1\u00f1ez L, de Zegher F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol Med. 2023;29:354\u201363.","journal-title":"Trends Mol Med"},{"key":"22881_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520.","journal-title":"Endocr Rev"},{"key":"22881_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","volume":"16","author":"E Palioura","year":"2015","unstructured":"Palioura E, Diamanti-Kandarakis E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev Endocr Metab Disord. 2015;16:365\u201371.","journal-title":"Rev Endocr Metab Disord"},{"key":"22881_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"22881_CR62","doi-asserted-by":"publisher","DOI":"10.1159\/000375530","author":"SF Witchel","year":"2015","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ib\u00e1\u00f1ez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015. https:\/\/doi.org\/10.1159\/000375530.","journal-title":"Horm Res Paediatr"},{"key":"22881_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.21037\/tp.2017.09.11","volume":"6","author":"MK Kamboj","year":"2017","unstructured":"Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr. 2017;6:248\u201355.","journal-title":"Transl Pediatr"},{"key":"22881_CR64","doi-asserted-by":"crossref","unstructured":"Mezzapesa F, Dondi G, Coada CA, De Leo A, De Terlizzi F, Strigari L et al. Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental? Int J Gynecol Cancer. 2025;:101634.","DOI":"10.1016\/j.ijgc.2025.101634"},{"key":"22881_CR65","doi-asserted-by":"crossref","unstructured":"Baird DD, Patchel SA, Saldana TM, Umbach DM, Cooper T, Wegienka G et al. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African\u2002Americans. Am J Obstet Gynecol. 2020;223:402.e1-402.e18.","DOI":"10.1016\/j.ajog.2020.02.016"},{"key":"22881_CR66","doi-asserted-by":"publisher","first-page":"e5411","DOI":"10.1016\/j.ajog.2009.12.013","volume":"202","author":"MK Whiteman","year":"2010","unstructured":"Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA. Inpatient hospitalization for gynecologic disorders in the united States. Am J Obstet Gynecol. 2010;202:e5411\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"22881_CR67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","volume":"59","author":"LA Wise","year":"2016","unstructured":"Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016;59:2\u201324.","journal-title":"Clin Obstet Gynecol"},{"key":"22881_CR68","doi-asserted-by":"crossref","unstructured":"Yu O, Scholes D, Schulze-Rath R, Grafton J, Hansen K, Reed SD. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Am J Obstet Gynecol. 2018;219:591.e1-591.e8.","DOI":"10.1016\/j.ajog.2018.09.039"},{"key":"22881_CR69","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151:2433\u201342.","journal-title":"Endocrinology"},{"key":"22881_CR70","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","volume":"43","author":"Q Yang","year":"2022","unstructured":"Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev. 2022;43:678\u2013719.","journal-title":"Endocr Rev"},{"key":"22881_CR71","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344\u201355.","journal-title":"N Engl J Med"},{"key":"22881_CR72","doi-asserted-by":"publisher","first-page":"e055470","DOI":"10.1136\/bmjopen-2021-055470","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang M, Du J, Lu H, Xiang F, Mei H, Xiao H. Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the global burden of disease. BMJ Open. 2022;12:e055470.","journal-title":"BMJ Open"},{"key":"22881_CR73","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(16)30121-8","volume":"17","author":"C Sauvaget","year":"2016","unstructured":"Sauvaget C, Nishino Y, Konno R, Tase T, Morimoto T, Hisamichi S. Challenges in breast and cervical cancer control in Japan. Lancet Oncol. 2016;17:e305\u201312.","journal-title":"Lancet Oncol"},{"key":"22881_CR74","doi-asserted-by":"publisher","first-page":"109578","DOI":"10.1016\/j.envres.2020.109578","volume":"186","author":"T Liu","year":"2020","unstructured":"Liu T, Song Y, Chen R, Zheng R, Wang S, Li L. Solid fuel use for heating and risks of breast and cervical cancer mortality in China. Environ Res. 2020;186:109578.","journal-title":"Environ Res"},{"key":"22881_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brachy.2018.08.016","volume":"18","author":"BA Quinn","year":"2019","unstructured":"Quinn BA, Deng X, Colton A, Bandyopadhyay D, Carter JS, Fields EC. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival. Brachytherapy. 2019;18:29\u201337.","journal-title":"Brachytherapy"},{"key":"22881_CR76","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/146642409311300407","volume":"113","author":"S Dhamija","year":"1993","unstructured":"Dhamija S, Sehgal A, Luthra UK, Sehgal K. Factors associated with awareness and knowledge of cervical cancer in a community: implication for health education programmes in developing countries. J R Soc Health. 1993;113:184\u20136.","journal-title":"J R Soc Health"},{"key":"22881_CR77","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-017-0331-6","volume":"10","author":"F Deng","year":"2017","unstructured":"Deng F, Xu X, Lv M, Ren B, Wang Y, Guo W, et al. Age is associated with prognosis in serous ovarian carcinoma. J Ovarian Res. 2017;10:36.","journal-title":"J Ovarian Res"},{"key":"22881_CR78","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1186\/s12889-022-13861-y","volume":"22","author":"S Zhang","year":"2022","unstructured":"Zhang S, Cheng C, Lin Z, Xiao L, Su X, Zheng L, et al. The global burden and associated factors of ovarian cancer in 1990\u20132019: findings from the global burden of disease study 2019. BMC Public Health. 2022;22:1455.","journal-title":"BMC Public Health"},{"key":"22881_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2016.10.019","volume":"144","author":"M Matz","year":"2017","unstructured":"Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, et al. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. 2017;144:405\u201313.","journal-title":"Gynecol Oncol"},{"key":"22881_CR80","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jgo.2016.07.008","volume":"7","author":"WP Tew","year":"2016","unstructured":"Tew WP. Ovarian cancer in the older woman. J Geriatr Oncol. 2016;7:354\u201361.","journal-title":"J Geriatr Oncol"},{"key":"22881_CR81","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.32620","volume":"126","author":"SM Crafton","year":"2020","unstructured":"Crafton SM, Cohn DE, Llamocca EN, Louden E, Rhoades J, Felix AS. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries. Cancer. 2020;126:1217\u201324.","journal-title":"Cancer"},{"key":"22881_CR82","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10815-024-03341-0","volume":"42","author":"M Zhang","year":"2025","unstructured":"Zhang M, Feng J, Ma W, Qiu L, Wang D, Yang Z. Current status of fertility preservation procedures in gynecologic oncology: from a Chinese perspective. J Assist Reprod Genet. 2025;42:635\u201345.","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 4","key":"22881_CR83","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdy001","volume":"29","author":"I Ray-Coquard","year":"2018","unstructured":"Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, et al. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv1\u201318.","journal-title":"Ann Oncol"},{"key":"22881_CR84","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ygyno.2017.09.019","volume":"147","author":"JS Shah","year":"2017","unstructured":"Shah JS, Guerra R, Bodurka DC, Sun CC, Chisholm GB, Woodard TL. Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of society of gynecologic oncology members. Gynecol Oncol. 2017;147:497\u2013502.","journal-title":"Gynecol Oncol"},{"key":"22881_CR85","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.soncn.2019.02.002","volume":"35","author":"K Passarello","year":"2019","unstructured":"Passarello K, Kurian S, Villanueva V. Endometrial cancer: an overview of pathophysiology, management, and care. Semin Oncol Nurs. 2019;35:157\u201365.","journal-title":"Semin Oncol Nurs"},{"key":"22881_CR86","doi-asserted-by":"publisher","first-page":"12900","DOI":"10.1038\/s41598-023-40001-2","volume":"13","author":"P Qiu","year":"2023","unstructured":"Qiu P, He H, Zhao Y, Yang Z, Li S, Ni P, et al. Global disease burden attributed to unsafe sex in 204 countries and territories from 1990 to 2019: results from the global burden of disease study 2019. Sci Rep. 2023;13:12900.","journal-title":"Sci Rep"},{"key":"22881_CR87","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.4103\/0973-1482.179190","volume":"14 Supplement","author":"J-H Fang","year":"2018","unstructured":"Fang J-H, Yu X-M, Zhang S-H, Yang Y. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies. J Cancer Res Ther. 2018;14 Supplement:S184\u20139.","journal-title":"J Cancer Res Ther"},{"key":"22881_CR88","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0140-6736(08)60247-0","volume":"371","author":"SC Larsson","year":"2008","unstructured":"Larsson SC, Wolk A. Excess body fatness: an important cause of most cancers. Lancet. 2008;371:536\u20137.","journal-title":"Lancet"},{"key":"22881_CR89","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u201378.","journal-title":"Lancet"},{"key":"22881_CR90","doi-asserted-by":"publisher","first-page":"e1003706","DOI":"10.1371\/journal.pmed.1003706","volume":"18","author":"M Vithayathil","year":"2021","unstructured":"Vithayathil M, Carter P, Kar S, Mason AM, Burgess S, Larsson SC. Body size and composition and risk of site-specific cancers in the UK biobank and large international consortia: A Mendelian randomisation study. PLoS Med. 2021;18:e1003706.","journal-title":"PLoS Med"},{"key":"22881_CR91","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41366-022-01178-0","volume":"46","author":"JA Murtha","year":"2022","unstructured":"Murtha JA, Liu N, Birstler J, Hanlon BM, Venkatesh M, Hanrahan LP, et al. Obesity and obesity-related cancers: are there body mass index cut-points? Int J Obes (Lond). 2022;46:1770\u20137.","journal-title":"Int J Obes (Lond)"},{"key":"22881_CR92","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/GME.0000000000001822","volume":"28","author":"F Liu","year":"2021","unstructured":"Liu F, Cheung ECW, Lao TT. Obesity increases endometrial cancer risk in Chinese women with postmenopausal bleeding. Menopause. 2021;28:1093\u20138.","journal-title":"Menopause"},{"key":"22881_CR93","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ijc.22260","volume":"120","author":"T Bj\u00f8rge","year":"2007","unstructured":"Bj\u00f8rge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer. 2007;120:378\u201383.","journal-title":"Int J Cancer"},{"key":"22881_CR94","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1111\/cas.14667","volume":"111","author":"T Masuda","year":"2020","unstructured":"Masuda T, Ogawa K, Kamatani Y, Murakami Y, Kimura T, Okada Y. A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. Cancer Sci. 2020;111:4646\u201351.","journal-title":"Cancer Sci"},{"key":"22881_CR95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ygyno.2010.03.001","volume":"118","author":"N-H Jeong","year":"2010","unstructured":"Jeong N-H, Lee J-M, Lee J-K, Kim JW, Cho C-H, Kim S-M, et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol. 2010;118:24\u20138.","journal-title":"Gynecol Oncol"},{"key":"22881_CR96","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.bjc.6605158","volume":"101","author":"K Lindemann","year":"2009","unstructured":"Lindemann K, Vatten LJ, Ellstr\u00f8m-Engh M, Eskild A. The impact of BMI on subgroups of uterine cancer. Br J Cancer. 2009;101:534\u20136.","journal-title":"Br J Cancer"},{"key":"22881_CR97","doi-asserted-by":"publisher","first-page":"103895","DOI":"10.1016\/j.ebiom.2022.103895","volume":"77","author":"X Wang","year":"2022","unstructured":"Wang X, Glubb DM, O\u2019Mara TA. 10 Years of GWAS discovery in endometrial cancer: aetiology, function and translation. EBioMedicine. 2022;77:103895.","journal-title":"EBioMedicine"},{"key":"22881_CR98","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1245\/s10434-016-5134-2","volume":"23","author":"AGZ Eriksson","year":"2016","unstructured":"Eriksson AGZ, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, et al. Impact of obesity on Sentinel lymph node mapping in patients with newly diagnosed uterine Cancer undergoing robotic surgery. Ann Surg Oncol. 2016;23:2522\u20138.","journal-title":"Ann Surg Oncol"},{"key":"22881_CR99","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"22881_CR100","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/1541-7786.MCR-17-0466","volume":"16","author":"SS Sahoo","year":"2018","unstructured":"Sahoo SS, Lombard JM, Ius Y, O\u2019Sullivan R, Wood LG, Nahar P, et al. Adipose-Derived VEGF-mTOR signaling promotes endometrial hyperplasia and cancer: implications for obese women. Mol Cancer Res. 2018;16:309\u201321.","journal-title":"Mol Cancer Res"},{"key":"22881_CR101","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2020.02.009","volume":"476","author":"C Gu","year":"2020","unstructured":"Gu C, Yang H, Chang K, Zhang B, Xie F, Ye J, et al. Melatonin alleviates progression of uterine endometrial cancer by suppressing Estrogen\/ubiquitin C\/SDHB-mediated succinate accumulation. Cancer Lett. 2020;476:34\u201347.","journal-title":"Cancer Lett"},{"key":"22881_CR102","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34:4270\u20136.","journal-title":"J Clin Oncol"},{"key":"22881_CR103","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1007\/s00464-024-11274-z","volume":"38","author":"F Mezzapesa","year":"2024","unstructured":"Mezzapesa F, Di Costanzo S, Coad\u0103 CA, Bernante P, Balsamo F, Garelli S, et al. Combined robotic surgery for concomitant treatment of endometrial cancer and obesity. Surg Endosc. 2024;38:6691\u20139.","journal-title":"Surg Endosc"},{"key":"22881_CR104","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bjc.2017.162","volume":"117","author":"EV Bandera","year":"2017","unstructured":"Bandera EV, Lee VS, Qin B, Rodriguez-Rodriguez L, Powell CB, Kushi LH. Impact of body mass index on ovarian cancer survival varies by stage. Br J Cancer. 2017;117:282\u20139.","journal-title":"Br J Cancer"},{"issue":"Suppl 1 Suppl 1","key":"22881_CR105","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ijgo.13870","volume":"155","author":"IA Wichmann","year":"2021","unstructured":"Wichmann IA, Cuello MA. Obesity and gynecological cancers: A toxic relationship. Int J Gynaecol Obstet. 2021;155(Suppl 1 Suppl 1):123\u201334.","journal-title":"Int J Gynaecol Obstet"},{"key":"22881_CR106","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3945\/ajcn.2009.28415","volume":"91","author":"F Kolahdooz","year":"2010","unstructured":"Kolahdooz F, van der Pols JC, Bain CJ, Marks GC, Hughes MC, Whiteman DC, et al. Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr. 2010;91:1752\u201363.","journal-title":"Am J Clin Nutr"},{"key":"22881_CR107","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/aje\/kwy249","volume":"188","author":"R Arthur","year":"2019","unstructured":"Arthur R, Brasky TM, Crane TE, Felix AS, Kaunitz AM, Shadyab AH, et al. Associations of a healthy lifestyle index with the risks of endometrial and ovarian Cancer among women in the women\u2019s health initiative study. Am J Epidemiol. 2019;188:261\u201373.","journal-title":"Am J Epidemiol"},{"key":"22881_CR108","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1073\/pnas.0604008103","volume":"103","author":"H Yang","year":"2006","unstructured":"Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, et al. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A. 2006;103:10397\u2013402.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22881_CR109","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2471\/BLT.13.132118","volume":"92","author":"T Kameda","year":"2014","unstructured":"Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park E-K, et al. Asbestos: use, bans and disease burden in Europe. Bull World Health Organ. 2014;92:790\u20137.","journal-title":"Bull World Health Organ"},{"key":"22881_CR110","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/ijerph15051000","volume":"15","author":"S Furuya","year":"2018","unstructured":"Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global asbestos disaster. Int J Environ Res Public Health. 2018;15:1000.","journal-title":"Int J Environ Res Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22881-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22881-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:04:50Z","timestamp":1747188290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22881-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22881"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22881-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1774"}}